Clinical trial
A Phase 1, Open-Label, Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VH4527079, Administered Either Intravenously or Subcutaneously to Healthy Adults and Persons With HIV
NCT06652958 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Open-Label, Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VH4527079, Administered Either Intravenously or Subcutaneously to Healthy Adults and Persons With HIV
- Lead sponsor
- ViiV Healthcare
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- October 2, 2024
- Completion date
- September 9, 2026
- Enrollment
- 102 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.